Midline 1 interacting protein 1 promotes cancer metastasis through FOS-like 1-mediated matrix metalloproteinase 9 signaling in HCC
Authors:
- Yung-Tuen ChiuYCYung-Tuen Chiu
- Abdullah HusainAHAbdullah Husain
- Karen Man-Fong SzeKSKaren Man-Fong Sze
- Daniel Wai-Hung HoDHDaniel Wai-Hung Ho
- Eliana Mary Senires SuarezESEliana Mary Senires Suarez
- Xia WangXWXia Wang
- Eva LeeELEva Lee
- Hoi-Tang MaHMHoi-Tang Ma
- Lo-Kong ChanLCLo-Kong Chan
- Irene Oi-Lin NgINIrene Oi-Lin Ng
Open Access
- 13 January 2023
- journal article
- research article
- Published by Wolters Kluwer Health in Hepatology
- Vol. 78 (5) , 1368-1383
Abstract
Background and Aims: Understanding the mechanisms of HCC progression and metastasis is crucial to improve early diagnosis and treatment. This study aimed to identify key molecular targets involved in HCC metastasis. Approach and Results: Using whole-transcriptome sequencing of patients’ HCCs, we identified and validated midline 1 interacting protein 1 (MID1IP1) as one of the most significantly upregulated genes in metastatic HCCs, suggesting its potential role in HCC metastasis. Clinicopathological correlation demonstrated that MID1IP1 upregulation significantly correlated with more aggressive tumor phenotypes and poorer patient overall survival rates. Functionally, overexpression of MID1IP1 significantly promoted the migratory and invasive abilities and enhanced the sphere-forming ability and expression of cancer stemness-related genes of HCC cells, whereas its stable knockdown abrogated these effects. Perturbation of MID1IP1 led to significant tumor shrinkage and reduced pulmonary metastases in an orthotopic liver injection mouse model and reduced pulmonary metastases in a tail-vein injection model in vivo. Mechanistically, SP1 transcriptional factor was found to be an upstream driver of MID1IP1 transcription. Furthermore, transcriptomic sequencing on MID1IP1-overexpressing HCC cells identified FOS-like 1 (FRA1) as a critical downstream mediator of MID1IP1. MID1IP1 upregulated FRA1 to subsequently promote its transcriptional activity and extracellular matrix degradation activity of matrix metalloproteinase MMP9, while knockdown of FRA1 effectively abolished the MID1IP1-induced migratory and invasive abilities. Conclusions: Our study identified MID1IP1 as a regulator in promoting FRA1-mediated-MMP9 signaling and demonstrated its role in HCC metastasis. Targeting MID1IP1-mediated FRA1 pathway may serve as a potential therapeutic strategy against HCC progression.Keywords
This publication has 31 references indexed in Scilit:
- Androgen up-regulates vascular endothelial growth factor expression in prostate cancer cells via an Sp1 binding siteMolecular Cancer, 2013
- Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9): The next decadeCritical Reviews in Biochemistry and Molecular Biology, 2012
- Induced polymerization of mammalian acetyl-CoA carboxylase by MIG12 provides a tertiary level of regulation of fatty acid synthesisProceedings of the National Academy of Sciences, 2010
- Overlapping Roles of the Glucose-Responsive Genes, S14 and S14R, in Hepatic LipogenesisEndocrinology, 2010
- Gelatinase-mediated migration and invasion of cancer cellsBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2005
- The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisitedNature Reviews Cancer, 2003
- Multistep Nature of Metastatic InefficiencyThe American Journal of Pathology, 1998
- Elevated plasma levels of matrix metalloproteinase-9 (92-kd type IV collagenase/gelatinase B) in hepatocellular carcinomaHepatology, 1996
- Overexpression of Matrix Metalloproteinase 9 Gene in Hepatocellular Carcinoma With Invasive PotentialHepatology, 1996
- Overexpression of matrix metalloproteinase 9 gene in hepatocellular carcinoma with invasive potentialHepatology, 1996